CARMAT obtains a €1.4 million grant as part of the “Industrial recovery plan – Strategic sectors” call for projects

CARMAT  (FR0010907956,  ALCAR), the designer and developer of the world’s most advanced total artificial  heart,  aiming  to  fulfill  an  unmet  medical  need  by  providing  a  therapeutic  alternative  to  people suffering from end-stage biventricular heart failure, today announces that is has obtaineda €1.4 million grantas  a  winner  of  theMinistry  for  Industry’s “Industrial  recovery  plan –Strategic sectors” call  for projects.

This non-dilutive financingwill contribute to the“CAP23” industrialization programthat aims tosize theproduction of the Aeson® heart for its commercial phase, notably by

• increasingCARMAT’s production capacity on itsBois-d’Arcyindustrial site
• digitalizing this site;and
• strengtheningthe Company’s network of industrial suppliers inFrance.